David Evans
Directeur Technique/Scientifique/R&D chez SIRNAOMICS LTD.
Fortune : 66 997 $ au 30/04/2024
Profil
David Mark Evans is the founder of Sirnaomics, Inc. (founded in 2007) and Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
(founded in 2008), where he holds the titles of Chief Scientific Officer and Executive Director respectively.
He is currently the Executive Director and Chief Scientific Officer at Sirnaomics Ltd.
since 2021.
Dr. Evans was a Senior Director at Dharmacon, Inc. and Vice President-Operations at Emerald BioStructures, Inc. in 2012.
Dr. Evans received his undergraduate and doctorate degrees from Imperial College Business School in 1983 and 1988 respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SIRNAOMICS LTD.
0,09% | 24/11/2023 | 76 162 ( 0,09% ) | 66 997 $ | 30/04/2024 |
Postes actifs de David Evans
| Sociétés | Poste | Début |
|---|---|---|
| SIRNAOMICS LTD. | Directeur Technique/Scientifique/R&D | 12/07/2021 |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Fondateur | 01/01/2007 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Fondateur | 10/03/2008 |
Anciens postes connus de David Evans
| Sociétés | Poste | Fin |
|---|---|---|
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a private company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Directeur des opérations | 01/12/2012 |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Directeur/Membre du Conseil | - |
Formation de David Evans
| Imperial College Business School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIRNAOMICS LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a private company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Commercial Services |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
